2023 - Research.com Medicine in United Kingdom Leader Award
2022 - Research.com Best Scientist Award
2022 - Research.com Medicine in United Kingdom Leader Award
Fellow of the American College of Cardiology (ACC)
His scientific interests lie mostly in Internal medicine, Atrial fibrillation, Cardiology, Stroke and Warfarin. His studies in Internal medicine integrate themes in fields like Endocrinology and Surgery. His work carried out in the field of Atrial fibrillation brings together such families of science as Hazard ratio, Anesthesia, Risk assessment and Antithrombotic.
In his study, Vascular disease and Fibrinogen is strongly linked to Von Willebrand factor, which falls under the umbrella field of Cardiology. His research integrates issues of Vitamin K antagonist, Anticoagulant, Apixaban, Aspirin and Risk factor in his study of Stroke. His Warfarin research incorporates themes from Lower risk and Physical therapy.
Gregory Y.H. Lip mainly focuses on Internal medicine, Atrial fibrillation, Cardiology, Stroke and Warfarin. His study on Heart failure, Hazard ratio and Myocardial infarction is often connected to In patient as part of broader study in Internal medicine. His study looks at the relationship between Atrial fibrillation and fields such as Intensive care medicine, as well as how they intersect with chemical problems.
Gregory Y.H. Lip has researched Cardiology in several fields, including Thrombosis, Surgery and Blood pressure. His Stroke study combines topics from a wide range of disciplines, such as Diabetes mellitus, Aspirin, Risk assessment and Risk factor. Gregory Y.H. Lip has included themes like Anticoagulant, Anesthesia and Randomized controlled trial in his Warfarin study.
Gregory Y.H. Lip mainly investigates Atrial fibrillation, Internal medicine, Cardiology, Stroke and In patient. His Atrial fibrillation course of study focuses on Intensive care medicine and MEDLINE. His research in Internal medicine tackles topics such as Diabetes mellitus which are related to areas like Kidney disease.
His Cardiology study combines topics in areas such as Blood pressure and Risk factor. The Stroke study combines topics in areas such as Adverse effect, Randomized controlled trial, Myocardial infarction and Emergency medicine. Gregory Y.H. Lip interconnects Proportional hazards model and Cohort study in the investigation of issues within Hazard ratio.
Internal medicine, Atrial fibrillation, Stroke, Cardiology and Hazard ratio are his primary areas of study. Gregory Y.H. Lip undertakes multidisciplinary investigations into Internal medicine and In patient in his work. His study in Atrial fibrillation is interdisciplinary in nature, drawing from both Lower risk, Heart failure and Intensive care medicine.
His Stroke study incorporates themes from Odds ratio, Adverse effect, Risk assessment and Comorbidity. His studies deal with areas such as Diabetes mellitus and Risk factor as well as Cardiology. His Hazard ratio research is multidisciplinary, incorporating elements of Integrated care and COPD.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski;Adriaan A. Voors;Stefan D. Anker;Héctor Bueno.
European Journal of Heart Failure (2016)
2007 Guidelines for the management of arterial hypertension
Giuseppe Mancia;Guy De Backer;Anna Dominiczak;Renata Cifkova.
European Heart Journal (2007)
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
Paulus Kirchhof;Stefano Benussi;Dipak Kotecha;Anders Ahlsson.
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
Gregory Y. H. Lip;Robby Nieuwlaat;Ron Pisters;Deirdre A. Lane.
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
John J.V. McMurray;Stamatis Adamopoulos;Stefan D. Anker;Angelo Auricchio.
European Journal of Heart Failure (2012)
2018 ESC/ESH Guidelines for the management of arterial hypertension.
Bryan Williams;Giuseppe Mancia;Wilko Spiering;Enrico Agabiti Rosei.
European Heart Journal (2018)
A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.
Ron Pisters;Deirdre A. Lane;Robby Nieuwlaat;Cees B. de Vos.
2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design
Hugh Calkins;Karl Heinz Kuck;Riccardo Cappato;Josep Brugada.
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
A. John Camm;Gregory Y.H. Lip.
European Heart Journal (2012)
Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.
Frans Van de Werf;Jeroen Bax;Amadeo Betriu;Carina Blomstrom-Lundqvist.
European Heart Journal (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: